Advisor Partners’s Tenet Healthcare THC Stock Holding History

Advisor Partners’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,639	Closed	-$227K	–	895
2022 Q1	$227K	Sell	2,639 -22	-0.8%	-$1.81K	0.01%	774
2021 Q4	$218K	Buy	+2,661	New	+$194K	0.01%	792

Other funds holding THC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCA

Canyon Capital Advisors Dallas, Texas $882M AUM 62.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Advisor Partners's THC Position: Q2 2022 in Review

Advisor Partners sold out of Tenet Healthcare (THC) in Q2 2022, closing a stake of 2,639 shares — an estimated $227K sold.

Advisor Partners first reported a position in THC in Q4 2021 and held it in 2 quarters. The position peaked at $227K in Q1 2022. 373 funds tracked by Wall St. Rank hold THC as of Q2 2022.

Advisor Partners reported no remaining Tenet Healthcare position as of Q2 2022 after selling out during the quarter.
Advisor Partners sold 2,639 Tenet Healthcare shares in Q2 2022, an estimated $227K.
Advisor Partners first reported a position in Tenet Healthcare in Q4 2021 and held it in 2 quarters.
Advisor Partners's Tenet Healthcare position peaked at $227K in Q1 2022.
373 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2022.

Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.